Barclays PLC View Ray, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.01 - $0.43 $19,878 - $854,780	-1,987,861 Reduced 99.76%	4,735 $0
Q2 2023 Aug 03, 2023	SELL	$0.35 - $3.28 $351,389 - $3.29 Million	-1,003,970 Reduced 33.5%	1,992,596 $703,000
Q1 2023 May 04, 2023	BUY	$3.28 - $4.81 $9.27 Million - $13.6 Million	2,827,578 Added 1673.24%	2,996,566 $10.4 Million
Q4 2022 Feb 13, 2023	BUY	$3.65 - $4.82 $492,870 - $650,859	135,033 Added 397.68%	168,988 $757,000
Q3 2022 Nov 03, 2022	SELL	$2.66 - $3.97 $3,066 - $4,577	-1,153 Reduced 3.28%	33,955 $124,000
Q2 2022 Aug 12, 2022	SELL	$2.42 - $4.05 $58,837 - $98,467	-24,313 Reduced 40.92%	35,108 $93,000
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $1.39 Million - $2.34 Million	-401,532 Reduced 87.11%	59,421 $233,000
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $1.98 Million - $3.07 Million	404,388 Added 714.91%	460,953 $2.54 Million
Q3 2021 Nov 09, 2021	SELL	$5.18 - $7.41 $1.8 Million - $2.58 Million	-347,950 Reduced 86.02%	56,565 $408,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $6.75 $1.13 Million - $1.94 Million	287,599 Added 245.99%	404,515 $2.67 Million
Q1 2021 May 13, 2021	BUY	$4.03 - $7.25 $325,950 - $586,387	80,881 Added 224.45%	116,916 $510,000
Q4 2020 Feb 11, 2021	SELL	$2.78 - $4.5 $42,486 - $68,773	-15,283 Reduced 29.78%	36,035 $137,000
Q3 2020 Nov 12, 2020	SELL	$2.12 - $3.53 $22,631 - $37,682	-10,675 Reduced 17.22%	51,318 $180,000
Q2 2020 Aug 12, 2020	SELL	$1.66 - $2.73 $14,727 - $24,220	-8,872 Reduced 12.52%	61,993 $138,000
Q1 2020 May 13, 2020	SELL	$1.35 - $4.05 $404,477 - $1.21 Million	-299,613 Reduced 80.87%	70,865 $177,000
Q4 2019 Feb 10, 2020	SELL	$2.3 - $4.6 $3.97 Million - $7.94 Million	-1,725,020 Reduced 82.32%	370,478 $1.56 Million
Q3 2019 Nov 14, 2019	BUY	$2.9 - $9.56 $5.79 Million - $19.1 Million	1,997,240 Added 2032.65%	2,095,498 $6.08 Million
Q2 2019 Aug 14, 2019	SELL	$6.7 - $9.13 $1.06 Million - $1.45 Million	-158,513 Reduced 61.73%	98,258 $865,000
Q1 2019 May 15, 2019	BUY	$5.7 - $8.73 $435,708 - $667,321	76,440 Added 42.39%	256,771 $1.9 Million
Q4 2018 Feb 14, 2019	BUY	$5.04 - $10.28 $84,752 - $172,868	16,816 Added 10.28%	180,331 $1.09 Million
Q3 2018 Nov 14, 2018	BUY	$7.12 - $12.44 $94,318 - $164,792	13,247 Added 8.82%	163,515 $1.53 Million
Q2 2018 Aug 14, 2018	BUY	$6.21 - $8.21 $777,659 - $1.03 Million	125,227 Added 500.09%	150,268 $1.04 Million
Q1 2018 May 15, 2018	BUY	$6.26 - $10.12 $126,383 - $204,312	20,189 Added 416.1%	25,041 $161,000
Q4 2017 Feb 14, 2018	SELL	$5.6 - $9.9 $10,987 - $19,423	-1,962 Reduced 28.79%	4,852 $45,000
Q3 2017 Nov 14, 2017	BUY	$4.73 - $6.16 $32,230 - $41,974	6,814	6,814 $39,000

Others Institutions Holding VRAY

# of Institutions

Shares Held

645K

Call Options Held

50K

Put Options Held

30K

View Full List

About ViewRay, Inc.

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

More about VRAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account